Abstract:The prolonged lag in T cell recovery seen in older patients undergoing hematopoietic stem cell transplant (HSCT), after chemo-/radiotherapy, can lead to immune dysfunction. As a result, recovering patients may experience a relapse in malignancies and opportunistic infections, leading to high mortality rates. The delay in T cell recovery is partly due to thymic involution, a natural collapse in the size and function of the thymus, as individuals age, and partly due to the damage sustained by the thymic stromal cells through exposure to chemo-/radiotherapy. There is a clear need for new strategies to accelerate intrathymic T cell reconstitution when treating aged patients to counter the effects of involution and cancer therapy regimens. Adoptive transfer of human progenitor T (proT) cells has been shown to accelerate T cell regeneration in radiation-treated young mice and to restore thymic architecture in immunodeficient mice. Here, we demonstrate that the adoptive transfer of in vitro -generated proT cells in aged mice (18-24 months) accelerated thymic reconstitution after treatment with chemotherapy and gamma irradiation compared to HSCT alone. We noted that aged mice appeared to have a more limited expansion of CD4-CD8- thymocytes and slower temporal kinetics in the development of donor proT cells into mature T cells, when compared to younger mice, despite following the same chemo/radiation regimen. This suggests a greater resilience of the young thymus compared to the aged thymus. Nevertheless, newly generated T cells from proT cell engrafted aged and young mice were readily present in the periphery accelerating the reappearance of new naïve T cells. Accelerated T cell recovery was also observed in both aged and young mice receiving both proT cells and HSCT. The strategy of transferring proT cells can potentially be used as an effective cellular therapy in aged patients to improve immune recovery and reduce the risk of opportunistic infections post-HSCT.

RANKL treatment restores thymic function and improves T cell–mediated immune responses in aged mice

Recombinant FOXN1 fusion protein increases T cell generation in aged mice

Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ

Thymus Reconstitution in Young and Aged Mice Is Facilitated by In Vitro-Generated Progenitor T Cells

Regeneration of Dendritic Cells in Aged Mice

Resveratrol ameliorates thymus senescence changes in D-galactose induced mice

Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice

“Inflamm‐aging” influences immune cell survival factors in human bone marrow

Critical role of the CD44lowCD62Llow CD8+ T cell subset in restoring antitumor immunity in aged mice

Rab8a restores diverse innate functions in CD11c + CD11b + dendritic cells from aged mice

Recombinant FOXN1 fusion protein increases T cell generation in old mice

T cell receptor excision circle assessment of thymopoiesis in aging mice

Thymic microenvironment's impact on immunosenescence

Atrophied thymus creates tTreg repertoire holes altering an antigen-specific population in the periphery

Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence

Age-related epithelial defects limit thymic function and regeneration

Thymic atrophy creates holes in Treg-mediated immuno-regulation via impairment of an antigen-specific clone

AAV-mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice

A role for altered TLR gene expression in association with increased expression of CD200R in the induction of mucosal tissue CD4(+) Treg in aged mice following gavage with a liver extract along with intramuscular monophosphoryl lipid A (MPLA) injection

Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination